Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder
Clinical trial NCT03187769 · COMPLETED
Trial details
- NCT number
- NCT03187769
- Sponsor
- Alkermes, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-08
- Primary completion
- 2021-12-01
- Enrollment
- 426
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.